Scientists used CRISPR to make prostate cancer cells easier for the immune system to detect and destroy. The experimental ...

Prostate cancer is one of the most common cancers diagnosed in men. Although it is the second-leading cause of cancer-related deaths for men in the U.S., it is also highly treatable, especially when ...

Prostate cancer is a disease in which cancer cells form in the tissues of the prostate, a gland in the male reproductive system. The National Cancer Institute states that about 1 in 8 males will be ...

An NHS trial over 10 years followed nearly 3,500 men who received focal therapy, a less invasive treatment.

The UCSF Helen Diller Family Comprehensive Cancer Center announced today that the UCSF Prostate Cancer Program is the recipient of the National Cancer Institute’s (NCI) Specialized Programs of ...

Think you know the signs of prostate cancer? Discover the subtle urinary changes many men ignore that could be a vital early ...

Focal therapy is as effective as surgery and radiotherapy for localized prostate cancer while significantly reducing the risk ...

LOS ANGELES, June 22, 2026 /PRNewswire/ -- The Ellison Medical Institute (EMI) has entered into an exclusive license with UniQuest, the commercialization company of The University of Queensland (UQ), ...

FORT MYERS, Fla., Jan. 22, 2026 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) is among the first oncology providers in Florida selected to enroll patients in a phase 3 ...

Prostate cancer often develops silently, with many patients experiencing no symptoms in its early stages. When symptoms do ...

According to the institute, a single, reliable test to differentiate aggressive, life-threatening cancers from slower-growing forms is lacking.

Learn what not to say to someone with prostate cancer and discover supportive alternatives to help loved ones feel heard, ...